Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07MJJ
|
|||
| Drug Name |
PMID25522065-Compound-8
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ALBANY MOLECULAR RESEARCH, INC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C26H25N3O2
|
|||
| Canonical SMILES |
CN1C2=C(C=CC(=C2)N3C=CC(=CC3=O)OCC4=CC=CC=C4)C5=C1C6CCN(C6)C5
|
|||
| InChI |
1S/C26H25N3O2/c1-27-24-13-20(7-8-22(24)23-16-28-11-9-19(15-28)26(23)27)29-12-10-21(14-25(29)30)31-17-18-5-3-2-4-6-18/h2-8,10,12-14,19H,9,11,15-17H2,1H3
|
|||
| InChIKey |
UPOGSKZLDRHZBU-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Melanin-concentrating hormone receptor 1 (MCHR1) | Target Info | Antagonist | [1] |
| Target's Patent Info | Melanin-concentrating hormone receptor 1 (MCHR1) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Peptide ligand-binding receptors | |||
| G alpha (q) signalling events | ||||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Gastrin-CREB signalling pathway via PKC and MAPK | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel MCH1 receptor antagonists: a patent review.Expert Opin Ther Pat. 2015 Feb;25(2):193-207. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.